SACITUZUMAB
UNII 73H2I6QS54

Substance Identification & Data

This profile provides standardized clinical and technical data for Sacituzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 73H2I6QS54.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1796566-95-4 and the RxNorm Concept ID (RxCUI) 2360231. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

73H2I6QS54

CAS Registry Number

1796566-95-4

RxNorm Concept ID

2360231

Detailed Substance Profile

Preferred Name

SACITUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152280

National Cancer Institute reference terminology for clinical and research data.

INN ID

10418

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-23

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sacituzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SACITUZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2) (HUMAN-MUS MUSCULUS MONOCLONAL HRS7 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HRS7 .KAPPA.-CHAIN, DIMER

SACITUZUMAB [INN]

SACITUZUMAB [USAN]